title: Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.
abstract: The mouse mammary carcinoma TS/A, of BALB/c (H-2d) origin, was transfected with the murine interferon-gamma (IFN-gamma) gene (Int. J. Cancer 55: 320, 1993). We used IFN-gamma transfectants as recipients for a second round of transfections with murine allogeneic class I histocompatibility (H-2b) genes that are modulated by IFN. Transfectants with either gene alone, as well as parent TS/A cells (TS/A-pc), were used as controls. Only double transfectants expressed high levels of the allogeneic H-2b genes, while in H-2b single transfectants the expression was very low (but was induced by treatment with exogenous IFN-gamma). The tumorigenic potential of IFN-gamma or H-2b single transfectants was reduced in comparison to TS/A-pc. IFN-gamma+H-2Kb double transfectants were almost nontumorigenic, while IFN-gamma+H-2Db clones gave rise to tumors in about one-half of mice. The experimental metastatic ability of all IFN-gamma+H-2b double transfectants was very low. IFN-gamma single transfectants were known to induce a strong macrophage response in the host. The expression of allogeneic H-2 antigens added a T-lymphocyte-mediated response that accounted for the lower tumorigenicity of double transfectants. These results show that it is possible to steer the immune response evoked by tumor cells for therapeutic purposes. Moreover, the high H-2 expression obtained in IFN-gamma+H-2b double transfectants suggests that single IFN-gamma transfectants are ideal recipients for all IFN-sensitive genes. This approach can be used also for other general-purpose inducers of gene expression.
authors.affiliation: Istituto di Cancerologia, Università di Bologna, Italy.
authors.forename: P L
authors.initials: PL
authors.lastname: Lollini
authors.forename: C
authors.initials: C
authors.lastname: De Giovanni
authors.forename: L
authors.initials: L
authors.lastname: Landuzzi
authors.forename: G
authors.initials: G
authors.lastname: Nicoletti
authors.forename: F
authors.initials: F
authors.lastname: Frabetti
authors.forename: F
authors.initials: F
authors.lastname: Cavallo
authors.forename: M
authors.initials: M
authors.lastname: Giovarelli
authors.forename: G
authors.initials: G
authors.lastname: Forni
authors.forename: A
authors.initials: A
authors.lastname: Modica
authors.forename: A
authors.initials: A
authors.lastname: Modesti
mesh_terms: D000818:Animals; D003602:Cytotoxicity, Immunologic; D005260:Female; D006183:H-2 Antigens / Q000235:genetics*; D016867:Immunocompromised Host; D007371:Interferon-gamma / Q000235:genetics*; D008325:Mammary Neoplasms, Experimental / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009362:Neoplasm Metastasis / Q000235:genetics* / Q000517:prevention & control; D014161:Transduction, Genetic; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: D006183:H-2 Antigens; D007371:Interferon-gamma